Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 950 - файл

patient groups. This can be in terms of therapies, treatments or interventions needed to address the problems or deficiencies they face in patient care. In some cases they will themselves be looking for already established innovations and practices and considering if these could be adapted or “trans lated” to the needs of their own patients. Some of them will be innovating and exploring on a regular basis (Maj­mudar et al. 2015) in the techniques and practices they apply in order to solve clinical problems and needs they face. Through this approach they may themselves become the pioneers and innovators of new therapies. Industries in the medical sector also have a place in this process and are themselves continually seeki ng to understand such unmet needs in areas that fit their business strategy, so that they can direct their own innovation engines and processes to developing novel interventions. They would then seek to translate these into clinical practice and commercialisation in partnership with healthcare professionals. Indeed, a clinician may well approach a company to seek their help if they see no immediate solution to hand or if they need or require wider resources, to move an idea forward collaboratively. This partnership can provide the perfect team to translate a clinical solution to everyone’s, and most importantly, the patients’, benefit (Tolikas et al. 2017).